Status:
UNKNOWN
Accuracy of Coplanar Template Assistance for Abdominal Tumor Puncture
Lead Sponsor:
Peking University Third Hospital
Conditions:
Abdominal Tumor
Eligibility:
All Genders
18-85 years
Brief Summary
In recent years, template guidance has been applied and developed in the field of puncture related operations, such as template-assisted radioactive seed implantation. With the guidance of template, n...
Eligibility Criteria
Inclusion
- Ages 18 to 85
- Single or multiple abdominal tumors or mass (solid, partially solid)
- Without taking drugs affecting coagulation and/or platelet aggregation are used; If used, the drug has been discontinued for a sufficient period of time (e.g. 1 week)
- KPS\>60 points, no serious or uncontrolled underlying diseases, clinical evaluation patients can tolerate puncture
- Planned biopsy and/or fiducial marker implantation with applicable puncture path
- With informed consent.
Exclusion
- Poor organ function (e.g. lung function FEV1\<40% and/or DLCO\<50%)
- The lesion close to blood vessels and intestine, or there is portal vein hypertension and superior vena cava compression, etc., which are expected to have high risks of puncture bleeding and intestinal injury
- Poor compliance, unable to complete coordination
- Paticipant who is considered inappropriate or unwilling to participate in this clinical trial for other reasons.
Key Trial Info
Start Date :
June 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 10 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05408819
Start Date
June 10 2022
End Date
February 10 2024
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiation Oncology of Peking university third hospital
Beijing, China